Geometry.Net - Health_Conditions: Hyperlipidemia

The Evaluation And Management Of Hyperlipidemia In HIV Infection
The Evaluation and Management of hyperlipidemia In HIV Infection Reported forNATAP by Carl J. Fichtenbaum, MD, Associate Professor of Clinical Medicine
http://www.natap.org/2000/icaac/ICAAC_hyperlipidemia_11070.htm

Extractions: Reported for NATAP by Carl J. Fichtenbaum, M.D., Associate Professor of Clinical Medicine, University of Cincinnati College of Medicine, Division of Infectious Diseases, University of Cincinnati College of Medicine ICAAC Report from Mike Norton, PA, Greenwich House, New York City. ICAAC, Tuesday, September 19, 2000. Symposium titled: Lipodystrophy and metabolic complications of HIV There were 4 separate presentations during this 2.5 hour session. William Lewis from Emory University was the first speaker. He made a compelling case for nucleoside induced mitochondrial dysfunction/destruction. Steven Grinspoon of Harvard presented glucose dysregulation. He noted that the changes being seen in treated patients are hyperinsulinemia and that this is often a prelude to diabetes. Typically one observes at the beginning of glucose dyregulation a normal fasting glucose but an abnormal 2 hour glucose after a 75gram glucose challenge. He called this state compensated normoglycemia.
Project ImPACT Hyperlipidemia
Project ImPACT hyperlipidemia. The APhA Foundation has completedProject ImPACT hyperlipidemia, a national demonstration project
http://www.connectforhealth.org/ProjectImPACTHyperlipidemia.htm

Extractions: Project ImPACT: Hyperlipidemia The APhA Foundation has completed Project ImPACT: Hyperlipidemia, a national demonstration project made possible by a grant from The abstract for the peer reviewed research article in the Journal of the American Pharmaceutical Association entitled Pharmaceutical Care and Results in Project ImPACT: Hyperlipidemia is provided below: Objective: To demonstrate that pharmacists, working collaboratively with patients and physicians and having immediate access to objective point-of-care patient data, promote patient persistence and compliance with prescribed dyslipidemic therapy that enables patients to achieve their National Cholesterol Education Program (NCEP) goals. Design: Observational study. Participants: 26 community-based ambulatory care pharmacies: independent, chainprofessional, chaingrocery store, home health/home infusion, clinic, health maintenance organization/managed care. Main Outcome Measures: Rates of patient persistence and compliance with medication therapy and achievement of target therapeutic goals. Results: In a population of 397 patients over an average period of 24.6 months, observed rates for persistence and compliance with medication therapy were 93.6% and 90.1%, respectively, and 62.5% of patients had reached and were maintained at their NCEP lipid goal at the end of the project.
HealingWell.com - Medifocus Guides - Hyperlipidemia
HealingWell Medcenter Medifocus Guide hyperlipidemia/Hypercholesterolemia(CR008) Introduction What are the most common symptoms of hyperlipidemia?
http://www.healingwell.com/medcenter/hyperlipidemia.asp

Extractions: Cholesterol (also called lipid) is a fat-like substance that deposits in the walls of blood vessels. It can contribute to the development of heart disease in certain individuals. Hypercholesterolemia is the clinical term for high levels of cholesterol in the blood. Other related terms used are high cholesterol, hyperlipidemia, and dyslipidemia. While cholesterol is the most commonly referred-to element of the lipid profile, there are several elements that are tested, with differing significance of elevated or low levels. The desirable levels of the different elements vary somewhat depending on the presence of other risk factors of coronary artery disease (CAD).
Hyperlipidemia
An Approach to hyperlipidemia. Thomas hyperlipidemia. It is not necessaryto stop estrogen replacement in patients with hyperlipidemia. Fish Oil.
http://www.bouldermedicalcenter.com/Articles/hyperlipidemia.htm

Extractions: SCREENING GUIDELINES: We have summarized below the current national recommendations. These recommendations need to be modified for individual patients. The rationale for screening for cholesterol problems rests on the observations that there is a direct relationship between cholesterol level and the risk of heart attacks and that lowering levels (at least in high-risk patients) leads to a reduction in heart attacks. More recently, other problems related to arteriosclerosis such as stroke have also shown to be correlated with cholesterol levels. As a result, screening should be done at least once every five years for all persons age 20 and over. On May 15, 2001 the National Cholesterol Education Program Total Cholesterol: stratified according the following criteria: HDL Cholesterol: "Good Cholesterol"; it is a negative risk factor for heart attack and is stratified according the following criteria: Very High — above 75 mg/dL (associated with the "longevity syndrome")
Cigarette Smoking, Dietary Hyperlipidemia, And Experimental Athe
McGilI, Jr. DATE; 1988 TITLE CIGARETTE SMOKING, DIETARY hyperlipidemia,AND EXPERIMENTAL ATHEROSCLEROSIS IN THE BABOON. CITATION
http://tobaccodocuments.org/pm/2063594156.html
Physician Education In Hyperlipidemia Management
Physician Education in hyperlipidemia Management The Impact on Collaboration.BARBARA S. CZERWINSKI, PhD, DAVID J. HYMAN, MD, MPH
http://www.sma.org/smj/97july5.htm

Extractions: THE IMPORTANCE of cholesterol management through diet modification and antihyperlipidemia drugs was emphasized in 1988 by guidelines from the National Cholesterol Education Program (NCEP) Expert Panel.1 In 1991, 46 million office visits were made for treatment of hyperlipidemia in the United States,2 costing an estimated $3.7 billion. The average office visit charge was $30, and the average cost for laboratory testing per visit was $50. The NCEP recommends diet and behavioral counseling as major components of hypercholesterolemia treatment. Counseling, however, is time consuming, and most physicians have limited time to counsel and to monitor their patients for behavioral changes necessary to positively alter cholesterol abnormalities. Collaborative practice, defined as physicians and other health care professionals working together as teams to promote patient health, has received renewed interest in this era of health care reform and limited resources.3-5 Collaborative practice has produced improved outcomes among (1) subjects in cardiovascular clinical trials,6 (2) patients in critical care settings,7 and (3) low-birth-weight infants.8 There has been little research on how to encourage physicians to adopt collaborative practice or on whether collaborative practice can be achieved via continuing medical education (CME) programs.
Hyperlipidemia Hypercholesterolemia
hyperlipidemia/ Hypercholesterolemia. Introduction. Other related termsused are high cholesterol, hyperlipidemia, and dyslipidemia.
http://www.medicalinfoplus.com/conditions/hyperlipidemia.html

Extractions: Cholesterol (also called lipid) is a fat-like substance that deposits in the walls of blood vessels. It can contribute to the development of heart disease in certain individuals. Hypercholesterolemia is the clinical term for high levels of cholesterol in the blood. Other related terms used are high cholesterol, hyperlipidemia, and dyslipidemia. While cholesterol is the most commonly referred-to element of the lipid profile, there are several elements that are tested, with differing significance of elevated or low levels. The desirable levels of the different elements vary somewhat depending on the presence of other risk factors of coronary artery disease (CAD).
Hospital Practice: Detecting And Correcting Hyperlipidemia
Detecting and Correcting hyperlipidemia RALPH R. HALL lipid levels. Diabetesand hyperlipidemia are a potentially deadly combination. The
http://www.hosppract.com/issues/1998/11/dmmhall.htm

Extractions: The dangers of elevated serum cholesterol levelsand in particular, of increased concentrations of small, dense lipoproteinshave been fully delineated. Although effective therapies are available, too many physicians fail to look for hypercholesterolemia, or fail to treat it effectively. Adhering to therapeutic guidelines and encouraging patient compliance can be lifesaving. Dr. Hall is Professor of Medicine Emeritus, University of Missouri-Kansas City School of Medicine, and Medical Education Director, Colorado Physician Education Program. Dr. Brunton is Clinical Professor, Department of Family Medicine, University of California, Irvine, College of Medicine, and Executive Vice President, Education and Scientific Affairs, Clinical Communications Group, Greenwich, Ct. Case 1 Presentation A 56-year-old postmenopausal woman, whose employer had recently changed insurance plans, presented to her new primary care physician. Two years earlier she had been diagnosed with non-insulin-dependent diabetes mellitus (NIDDM) and had been treated with a maximum dose of a sulfonylurea. Her most recent glycosylated hemoglobin level was 8.6%. The patient did not have a history of heart disease, but treatment with simvastatin, 20 mg a day, had been initiated by her former physician because of hyperlipidemia. The pretreatment lipid levels had been total cholesterol, 242 mg/dL; high-density lipoprotein (HDL), 43 mg/dL; low-density lipoprotein (LDL), 199 mg/dL; and triglycerides, 430 mg/dL. After eight weeks of treatment, the total cholesterol level had fallen to 179 mg/dL, the LDL to 134 mg/dL, and the triglycerides to 280 mg/dL. The HDL level was 45 mg/dL.
Diabetes Self-Management - Hyperlipidemia
hyperlipidemia Published in the May/June 2000 issue. A blanket term for abnormallyhigh levels of lipids, such as cholesterol, in the bloodstream.
http://www.diabetesselfmanagement.com/article.cfm?aid=396&sid=6
Florida State University College Of Medicine Digital Library
hyperlipidemia Clinical Resources. Miscellaneous hyperlipidemia Clinical ResourcesHealth Reviews for Primary Care Providers on the Internet Homepage
http://fsumed-dl.slis.ua.edu/clinical/cardiology/cardiovascular/hyperlipidemia.h

Extractions: Clinical Resources by Topic: Cardiovascular Disorders Hyperlipidemia Clinical Resources Pediatrics Geriatrics Genetics Clinical Guidelines ... Miscellaneous Resources See also: Hypocholesterolemia Access document Larsen: Williams Textbook of Endocrinology 10th Ed.-2003 (MD Consult): Table of contents Medical Library subscription INFO Plasma Lipoproteins: Apolipoproteins, Receptors, and Enzymes:
Florida State University College Of Medicine Digital Library
Cardiovascular Diseases. hyperlipidemia Prevention and Screening Resources. hyperlipidemia(Keyword search) List of documents. Miscellaneous hyperlipidemia
http://fsumed-dl.slis.ua.edu/prevmedicine/disease-prevention/cardiovasculardisor

Extractions: Preventive Medicine Resources by Topic: Cardiovascular Diseases Hyperlipidemia Prevention and Screening Resources Clinical Guidelines Miscellaneous Resources See also: Braunwald-Heart Disease: A Textbook of Cardiovascular Medicine 6th Ed.-2001 (MD Consult): Table of contents Medical Library subscription INFO Guide to Clinical Preventive Services, 3rd Ed., Table of contents Clinical Guidelines American Heart Association: Homepage Scientific Statements: List of documents Monounsaturated Fatty Acids and Risk of Cardiovascular Disease (1999): Access document Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and beta-Carotene (1999):
The Drug Monitor - Hyperlipidemia / Dyslipidemia - Nasr Anaizi, PhD
Management of hyperlipidemia During the past 10 years dramatic progress has madein the field of lipidlowering drugs and the management of hyperlipidemia.
http://www.thedrugmonitor.com/hyperlipidemia.html

Extractions: Please read the Antiinfectives General Rx Renal Rx Transplant Rx ... Clinical Tools Objectives Review the main risk factors for coronary heart disease (CHD) (per NCEP) Review of the basics of lipoprotein metabolism and the major lipid disorders. Review the guidelines for non-pharmacologic and pharmacologic management of hyperlipidemia. Review the current pharmacologic options for the treatment of hyperlipidemia. Review the pharmacology of atorvastatin. Discuss the latest clinical trials comparing atorvastatin to other statins. Coronary heart disease (CHD) is one the leading causes of disability and death in the US. Although the etiology of CHD is multifactorial, there is an impress amount of evidence from experimental, epidemiological, and clinical studies indicating a strong association between coronary artery atherosclerosis and hypercholesterolemia below summarizes the main risk factors predisposing patients for the development of CHD: Table 1
33. Prospective Study Of Hyperlipidemia In ART-Naïve Subjects Taking Combivir/A
Prospective Study of hyperlipidemia in ARTNaïve Subjects Taking Combivir/Abacavir(COM/ABC), COM/Nelfinavir (NFV), or Stavudine (d4T)/Lamivudine (3TC)/NFV
http://www.retroconference.org/2002/Abstract/13081.htm

Extractions: Background: Hyperlipidemia is a common side effect of HAART therapy. The effect that non-PI-containing regimens have on the development of hyperlipidemia and fat redistribution (FR) is not fully known. Our objectives were to evaluate changes in fasting metabolic parameters, clinical evaluations of FR, safety, and efficacy in subjects treated with COM/ABC vs COM/NFV vs d4T/3TC/NFV for 96 weeks.
Diseases And Conditions -- Discovery Health -- Familial Combined Hyperlipidemia
Familial combined hyperlipidemia is an inherited disease that causes highlevels of cholesterol and/or triglycerides in the blood.
http://health.discovery.com/diseasesandcond/encyclopedia/26.html

Extractions: familial combined hyperlipidemia By Evan M. Sisson, Pharm.D., MHA, CDE Familial combined hyperlipidemia is an inherited disease that causes high levels of cholesterol and/or triglycerides in the blood. What is going on in the body? This condition may cause high cholesterol , high triglycerides , or both. These are each two types of fat in the body. Normally, the liver makes a low amount of cholesterol. When a person has this disease, the liver produces too much cholesterol. Other problems occur with fat metabolism, too. These problems depend on which specific abnormal gene was inherited. This condition increases a person's risk of having clogged arteries from atherosclerosis , which may lead to a heart attack stroke , or other complications. What are the signs and symptoms of the condition? This condition often causes no symptoms. Once the arteries become clogged, a heart attack stroke , or other problems may occur. What are the causes and risks of the condition? This condition is inherited and occurs in about 1% of people in the US. What can be done to prevent the condition?
Hyperlipidemia
hyperlipidemia INDICATIONS FOR WHO SHOULD BE TREATED? hyperlipidemia refers to elevatedblood levels of lipids (fats), including cholesterol and triglycerides.
http://www.uptodate.com/patient_info/topicpages/topics/Hrt_dis/7390.asp

Extractions: The good news is that lipid levels can almost always be lowered with a combination of diet, weight loss, exercise, and medications. As lipid levels fall, so does the risk of developing CHD, as well as the risk of suffering a stroke. And, it is not too late if CHD is already present: lipid-lowering treatment in people with CHD can be lifesaving.
Hyperlipidemia - AnsMe.com Dictionary (define)
Dictionary hyperlipidemia. Show Definition. Sounds Similar. Relations. Rhymes.Translate. Definition for hyperlipidemia. hyperlipidemia (noun) -.
http://define.ansme.com/words/h/hyperlipidemia.html
Hyperlipidemia And Pancreatitis During..., Annals 15 Feb 96
hyperlipidemia and Pancreatitis during Pregnancy in Two Sisters with a Mutationin the Lipoprotein Lipase Gene. Annals of Internal Medicine 15 Feb 96.
http://www.acponline.org/journals/annals/15feb96/2sisters.htm

Extractions: Annals of Internal Medicine Current Issue Past Issues Library for Internists Subscriptions ... Email this page Annals of Internal Medicine Annals of Internal Medicine 15 February 1996. 124:425-428. Leonard M. Keilson, MD, MPH; Calvin P.H. Vary, PhD; Dennis L. Sprecher, MD; and Roger Renfrew, MD Objective: To explore genetic mechanisms for pregnancy-associated pancreatitis and hyperlipidemia in two sisters. Design: Case history. Setting: Tertiary care facility with outpatient follow-up. Patients: Two sisters with acute pancreatitis and the acute respiratory distress syndrome were admitted (patient 1) or transferred (patient 2) to an intensive care setting with severely elevated triglyceride levels. Patient 1 was in the last trimester of pregnancy; patient 2 was 1 month post-partum. Both patients were of French Canadian ancestry. Intervention: Acute treatment was directed at stabilizing both patients medically (with fat restriction) and one patient surgically (patient 2). Treatment with fat restriction, weight loss, and gemfibrozil was continued after hospitalization. Results: Through DNA sequencing, we detected a mutation at amino acid residue 188 of lipoprotein lipase (LPL), reflecting product from one allele of the LPL gene in which a glutamine residue was substituted for a glycine (gly188
ACP-ASIM - 2003 Annual Session
Email this page. Managing a Patient with hyperlipidemia. This session covered thetreatment of hyperlipidemia within the context of recently published trials.
http://www.acponline.org/vas2001/sessions/hyper.htm

Extractions: Guest Activities/San Diego Information Guest Activities Program/Spotlight on San Diego Printer-friendly format Email this page To register, call Customer Service at 800-523-1546, ext. 2600 or 215-351-2600. ACP-ASIM Learning Center Computers in Practice Handouts Program Support Faculty Index Disclosure of Significant Relationships Send a message to an Attendee Don't Miss These Special Events Annual Session Receptions San Diego Hotels Shuttle Bus Service Hotel and Travel Instructions Convocation ... Especially for ACP-ASIM Associates, Residents, Fellows-in-Training, and Medical Students
Hyperlipidemia And Angina
hyperlipidemia and Angina. Implementing Coronary Risk Factor ModificationWhy, How, and In Whom Presented by Jonathan Abrams, MD
http://www.acc.org/education/online/risks/hyperlipidemia/

Extractions: Because of the increased cardiovascular risk associated with elevated levels of total and LDL cholesterol, many investigators have studied the effects of lipid reduction in patients with coronary artery disease. The results have been encouraging. At this time, I would like to present recent findings about the benefits of one specific class of lipid-lowering drugs - the statins - in the treatment of angina pectoris. I will begin my discussion with a presentation of a case history of a patient with angina.
Hyperlipidemia
hyperlipidemia. by Chick Newman. Primary idiopathic hyperlipidemia has been reportedto be familial in Miniature Schnauzers and Beagles, and some mixed breeds.
http://www.newmanveterinary.com/Hyperlipidemia.html

Extractions: by Chick Newman Introduction Etiology Lipid Classification Graphics ... Treatment Introduction: Primary idiopathic hyperlipidemia has been reported to be familial in Miniature Schnauzers and Beagles, and some mixed breeds. It has been seen sporadically in other breeds, e.g. Poodles and Shelties, as well, Infrequently it has been reported in cats. Secondary hyperlipidemia occurs as a result of another disease process. For example, it has been seen in association with diabetes pancreatitis hyperadrenocorticism and hypothyroidism Etiology: This is a metabolically complex disease of lipid -lipoprotein metabolism and the exact etiology is not fully appreciated. The familial type in schnauzers may involve defects lipoprotein lipase and/or Apoprotein C-II , a required cofactor for lipoprotein lipase activity (see figure below for roles of enzyme and cofactors in lipid metabolism). This defect causes a failure to breakdown chylomicrons (most common) and/or VLDL , and results in excessive levels of circulating triglycerides. It is the elevated concentration of triglycerides that is responsible for the clinical signs Classification: Lipids are derived from exogenous chylomicrons ) and endogenous sources. Lipids have been classified as:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

61-80 of 97 Back | 1 | 2 | 3 | 4 | 5 | Next 20